NEW YORK (MarketWatch)—Big investors fell out of love with General Motors in the second quarter but hedge-fund titans including Dan Loeb rushed to snap up shares of Ally Financial, the troubled auto maker’s former financing arm that was rescued by the U.S. government, according to an analysis of freshly-filed regulatory documents.
Hedge funds and other heavyweights were also eager to take up new stakes in pharmaceutical firm Allergan Inc. AGN, -1.01% Google GOOGL, +0.93% The Williams Companies WMB, -0.14% and DirecTV DTV, +0.04% while eliminating stakes in eBay EBAY, +0.68% SLM Corp. SLM, +0.23% Vodafone VOD, +0.88% and Dollar General DG, +9.05% according to Whalewisdom.com, a website that tracks 13F and other regulatory filings.
Institutional investment managers with more than $100 million in certain types of assets have until 45 days after the end of a quarter to file a 13F form listing securities holdings with the Securities and Exchange Commission. The second-quarter filing deadline was Thursday. Whalewisdom provided a breakdown of the biggest aggregate purchases and sales by the 600 most closely-followed investors on its site.
Among Ally’s ALLY, +0.83% most ardent supporters, Loeb’s Third Point hedge fund acquired 45.6 million shares in the second quarter. The position made Ally Loeb’s second-largest holding as of June 30, according to the filing, equal to 13.4% of his overall portfolio and worth $1.09 billion at the end of the quarter.
Fellow hedge-fund titan John Paulson was also in the Ally camp, albeit on a smaller scale, holding a little over 2 million shares, worth nearly $48 million as of June 30. Stephen Feinberg, head of Cerberus Capital Management, took a Loeb-sized stake in the firm, snapping up more than 41.5 million shares worth nearly $993 million as of the end of the quarter.
Ally Financial was rescued by the U.S. government during the financial crisis. It made its debut in an initial public offering on April 10, a transaction that saw the Treasury Department raise nearly $2.4 billion by selling shares at $25 each. Ally soon dipped below its offering price and changed hands at $24.13 in recent action Friday, a 0.4% daily decline. Shares are down 0.2% since the beginning of the current quarter.
Now, 13F filings don’t offer a full picture of an investors’ positions. Also, the holdings are at least 45 days old. But they can offer insights into the thinking of big investors. Read more about 13Fs.
Big investors appeared to trade heavily during the second quarter in shares of Allergan, the pharmaceutical firm fighting a takeover effort by rival Valeant Pharmaceuticals. That takeover quest has been pushed by activist investor Bill Ackman, whose Pershing Square hedge fund added nearly 28.3 million shares to its stake in Allergan during the quarter. Allergan was Ackman’s top holding with a value of nearly $4.9 billion.
Other activists, including Paulson (who acquired a new stake of 5.6 million shares) also bought into Allergan. Shares of Allergan are up 41.3% since the beginning of the year, but have dropped 7.3% since June 30.
Also worth noting, hedge-fund legend George Soros significantly loaded up on puts on the SPDR S&P 500 ETF SPY, +0.59% while also adding to a smaller holding of calls on the same product. The move raised eyebrows among analysts, who pondered whether it belied a growing sense of caution for the otherwise apparently bullish Soros. See: Does George Soros know something we don’t about the S&P 500?
Meanwhile, positions in eBay were eliminated entirely by around 5.7% of filers, topping the list of sold-out positions, with big investors dumping a total of nearly 14.7 million shares. Billionaire investor Carl Icahn in April backed away from his contentious demand that eBay spin off its PayPal unit.
Icahn, however, was a buyer of eBay in the second quarter, his 13F filing showed, picking up 3 million shares. EBay shares have rebounded 5.3% since the beginning of the third quarter, trimming its year-to-date loss to 4%.
General Motors GM, +1.15% was dumped entirely by 5% of big filers as it worked through numerous recalls and scrutiny over vehicle safety. See: Booming demand seen in 10.1% surge in vehicle output.